Cholesterol Denialism is Pseudoscience
Early research on cholesterol’s role in atherosclerosis warranted skepticism, but there is no place for modern-day doubters given the supportive evidence for lipid lowering, writes Chris Labos, MD.
Early research on cholesterol’s role in atherosclerosis warranted skepticism, but there is no place for modern-day doubters given the supportive evidence for lipid lowering, writes Chris Labos, MD.
This CME-certified activity will focus on best practices in the care of patients with mUC.
AbstractCardiovascular disease (CVD) has increasing challenges for human health with an increasingly aging population worldwide, imposing a significant obstacle to the goal of healthy aging.…
The FDA requirement that drug companies implement a Risk Evaluation and Mitigation Strategy has, in some cases, been used to hinder competition from generic drugs…
The HFSA Heart Failure Seminar: Focus on Iron Deficiency will feature a multidisciplinary panel of experts presenting a case-based program that is designed to provide…
A new evaluation of the CLL-IPI revealed that its impact appears diminished in predicting OS in the era of targeted drugs.
Researchers evaluated differences in treatment intensification and overall survival between patient groups.
Dietary interventions could be considered as an initial treatment for patients with IBS, although more research is needed for personalized treatment plans.
A virtual platform for anemia consultation led by advanced practitioners provided “patient convenience and satisfaction,” according to research presented at JADPRO Live 2023.
Naveen Pemmaraju, MD, joins the Oncology Brothers, Rahul Gosain, MD, and Rohit Gosain, MD, to discuss the treatment of patients with myelofibrosis, focusing on diagnostic…
Show Heart Doc VIP with Dr. Joel Kahn, Ep Why You Must Know Your Heart Calcium Score – May 21, 2024